Online Resources: Rheumatoid Arthritis

Clinical Trial

Switching Anti-TNF-Alpha Agents in RA

Study Type: Interventional

Age/Gender Requirement: 18 years+ (male/female)

Sponsor: National Institute of Allergy and Infectious Diseases

Purpose: “To determine the effectiveness of switching to an alternative tumor necrosis factor (TNF) alpha inhibitor in comparison to continuing treatment with an existing TNF-alpha inhibitor.”

eAbstract

A Systematic Review of the Effects of Dynamic Exercise in Rheumatoid Arthritis

Journal: Rheumatology International (August 21, 2009)

Authors: Cairns AP, McVeigh JG

Purpose: “To determine the effects of dynamic exercise on patients with RA.”

Results: The review previous studies showed that “the majority of patients with RA should be encouraged to undertake aerobic and/or strength training exercise.”

CME

Infliximab May Be Helpful in Early Rheumatoid Arthritis Refractory to Methotrexate

Credits: 0.25

Fee: None

Expires: August 10, 2010

Multimedia: None

This activity discusses the results of a recent study that showed that infliximab may be a successful treatment option for patients with RA who did not respond to methotrexate. The program discusses “the efficacy of infliximab vs sulfasalazine and hydroxychloroquine added to methotrexate in patients with early rheumatoid arthritis.” Participants will also be able to describe any safety issues that may arise in taking infliximab rather than methotrexate.